These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 21049396)

  • 1. A unique issue in the standardization of Chinese materia medica: processing.
    Zhao Z; Liang Z; Chan K; Lu G; Lee EL; Chen H; Li L
    Planta Med; 2010 Dec; 76(17):1975-86. PubMed ID: 21049396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
    Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
    J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current global status of Chinese materia medica.
    Liu X; Zou J; Sheng Z; Su G; Chen S
    Phytother Res; 2009 Oct; 23(10):1493-5. PubMed ID: 19787664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Authentication is fundamental for standardization of Chinese medicines.
    Zhao Z; Hu Y; Liang Z; Yuen JP; Jiang Z; Leung KS
    Planta Med; 2006 Aug; 72(10):865-74. PubMed ID: 16902852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of mid-infrared spectroscopy in the quality control of traditional Chinese medicines.
    Sun S; Chen J; Zhou Q; Lu G; Chan K
    Planta Med; 2010 Dec; 76(17):1987-96. PubMed ID: 21049394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica.
    Xie PS; Leung AY
    J Chromatogr A; 2009 Mar; 1216(11):1933-40. PubMed ID: 18757061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese medicinal materials and their interface with Western medical concepts.
    Chan K
    J Ethnopharmacol; 2005 Jan; 96(1-2):1-18. PubMed ID: 15588645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation on pattern of quality control for Chinese materia medica based on famous-region drug and bioassay--the work reference].
    Yan D; Xiao X
    Zhongguo Zhong Yao Za Zhi; 2011 May; 36(9):1249-52. PubMed ID: 21842660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survey of investigations on Daodi Chinese medicinal materials in China since 1980s].
    Xiao X; Chen S; Huang L; Xiao P
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):519-23. PubMed ID: 19526774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Authentication of Chinese Materia Medica decoction dregs. Part II: comparison before and after decoction of four Chinese Materia Medica that mainly comprise storage tissue.
    Wong L; Liang Z; Chen H; Zhao Z
    Microsc Res Tech; 2012 Feb; 75(2):164-75. PubMed ID: 21761498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The classification and application of toxic Chinese materia medica.
    Liu X; Wang Q; Song G; Zhang G; Ye Z; Williamson EM
    Phytother Res; 2014 Mar; 28(3):334-47. PubMed ID: 23722570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination system for prediction of Chinese Materia Medica properties.
    Long W; Liu P; Xiang J; Pi X; Zhang J; Zou Z
    Comput Methods Programs Biomed; 2011 Mar; 101(3):253-64. PubMed ID: 21315471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current situation of toxicity classification of Chinese materia medica and its research thoughts].
    Sun W; Hou X; Wang B; Zhu Y; Zhang S; Chang H; Sun J
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2199-201. PubMed ID: 23189717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicological risks of Chinese herbs.
    Shaw D
    Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
    Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Several strategic consideration for the modernization of Chinese materia medica].
    Xiao PG; Liu Y
    Yao Xue Xue Bao; 2003 Jul; 38(7):485-6. PubMed ID: 14515789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substance basis research on Chinese materia medica is one of key scientific problems of inheriting, development and innovation of Chinese materia medica].
    Yang XW
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3429-34. PubMed ID: 26978985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features and development trends in international standardization of Chinese materia medica in ISO/TC 249.
    Xu XT; Shi YH; Sang Z; Zhou H
    Pharmacol Res; 2021 May; 167():105519. PubMed ID: 33636352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cause and measure of short of quality control on Chinese medicine herbs].
    Chen J; Chen L; An Z; Yu X; Zhan Y
    Zhong Yao Cai; 2003 Jan; 26(1):43-6. PubMed ID: 12858774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authentication of the 31 species of toxic and potent Chinese materia medica by microscopic technique assisted by ICP-MS analysis, part 4: four kinds of toxic and potent mineral arsenical CMMs.
    Li Q; Chu C; Wang YQ; Chen HB; Li P; Zhao ZZ
    Microsc Res Tech; 2011 Jan; 74(1):1-8. PubMed ID: 21181703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.